Remo-Zen

Remo-Zen (Remogliflozin Etabonate) belongs to the class of selective inhibitors of the sodium-glucose transport protein 2, which effectively reduce blood glucose and glycated hemoglobin. It is a modern drug, one of the latest advances in medicine used to treat type 2 diabetes and nonalcoholic fatty hepatosis. Also, Remo-Zen (Remogliflozin Etabonate) has a positive effect on blood pressure and contributes to weight loss in obese patients.

Always follow your doctor`s instructions when using Remo-Zen (Remogliflozin Etabonate) to get the safest and most effective results from treatment. Dosage and frequency of administration are determined by the doctor individually for each patient.

Tablets should be taken whole. Tablets cannot be divided, chewed or crushed.

The use of Remo-Zen (Remogliflozin Etabonate) may cause side effects in some patients including:

• nausea
• urinary tract infections
• fungal infections of the genital tract
• increased urination
• increased thirst
• hypoglycemia (low blood sugar), especially in combination with insulin or sulfonylurea

Contact your doctor immediately if you experience any serious or worrying symptoms.

When using Remo-Zen (Remogliflozin Etabonate), it is imperative to monitor blood glucose.

Carefully observe personal hygiene rules when taking Remo-Zen (Remogliflozin Etabonate), because it increases the risk of genital and urinary tract infection

There is insufficient data on the use of Remo-Zen (Remogliflozin Etabonate) during pregnancy and the effect on the fetus.

It is unknown whether Remo-Zen (Remogliflozin Etabonate) is excreted in human milk.

Before using the drug during pregnancy and breastfeeding, it is necessary to consult your doctor.